LanzaTech Announces Progress on Strategic Actions to Sharpen Business Focus and Improve Cost Structure

In This Article:

LanzaTech Inc.
LanzaTech Inc.

Executing initiatives to streamline priorities and drive approximately $30 million of annual cash operating expense reductions

Reschedules fourth quarter and full-year 2024 earnings conference call

CHICAGO, March 04, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, today announced progress on strategic actions being taken to transition the Company from an innovation hub to a profitable enterprise. Additionally, the Company has rescheduled its fourth quarter and full-year 2024 earnings call to March 31, 2025, to more closely align with the filing of its Annual Report on Form 10-K.

“Over the last two decades, LanzaTech has been at the forefront of carbon management innovation, pushing the boundaries to establish new products and markets," said Dr. Jennifer Holmgren, Chair and CEO of LanzaTech. “As we shift the Company’s focus from research and development to globally deploying our proven technology, we are pursuing partnership opportunities for technologies that are ready to stand on their own and sharpening our focus on high-impact commercial projects that align more with a path to profitability. As part of this transition, we continue to action plans to right-size our cost structure and expect to achieve significant annual cash cost savings as a result.”

Along with the recently announced intention to spin out the Company’s synthetic biology platform referred to as LanzaX, LanzaTech is evaluating scale up opportunities for its nutritional protein capabilities referred to as LanzaTech Nutritional Protein (“LNP”). This strategic approach is designed to enable these platforms to access the capital required to accelerate the development of their independent pipelines of existing projects. It will also enable LanzaTech to have a sharper focus on the growth priorities of the Company’s core biorefining operations, including the technology’s inclusion in integrated waste-based ethanol to Sustainable Aviation Fuel (“SAF”).

Examples of high-priority commercial projects under development include a project in the United Kingdom and a project in the European Union, each 30-million gallon per year, waste-based ethanol-to-SAF facilities that will leverage the LanzaTech and LanzaJet CirculAir™ solution to form an efficient and economically compelling offering that provides the aviation industry with a platform to produce waste-based SAF globally.

Additionally, the Company is implementing strategic measures to scale its business globally with greater cost efficiency. This includes evaluating its global footprint, with anticipated consolidations expected to reduce the workforce by approximately 10 to 15 percent. These measures, combined with the LanzaX and LNP strategic opportunities, and other cost savings plans, have the potential to result in approximately $30 million of annual cash operating expense reductions.